Literature DB >> 2983012

Use of enzyme-labeled antigen for the detection of immunoglobulin M and A antibody to herpes simplex virus in serum and cerebrospinal fluid.

A M van Loon, J T van der Logt, F W Heessen, J van der Veen.   

Abstract

A direct enzyme-linked immunosorbent assay (ELISA that used peroxidase-labeled antigen) was developed for detection of IgM and IgA antibody to herpes simplex virus (HSV). The assay uses immuno-affinity-purified antihuman IgM or IgA antibody-coated wells of microtiter plates to separate IgM or IgA from other classes of antibody in serum or cerebrospinal fluid (CSF). The presence of specific IgM or IgA is detected by subsequent, consecutive incubation with peroxidase-labeled antigen and substrate. HSV antigen was purified by sucrose gradient centrifugation and coupled with peroxidase by the periodate method. By examining sucrose-gradient-fractionated sera the assays were shown to be specific for IgM and IgA classes of antibody. None of the sera from patients with Epstein-Barr virus (n = 20), cytomegalovirus (n = 20), or varicella-zoster virus (n = 8) infection or with both rheumatoid factor and IgG antibody to HSV (n = 13) reacted positively. Only one out of 78 sera from healthy persons was positive for IgA antibody to HSV, and none for IgM antibody. All 33 patients with HSV infection developed HSV-IgA, 22 developed HSV-IgM. Of the 11 patients with primary infection, all had IgM antibody in their first sera and six had IgA antibody. The corresponding figures for the 22 patients with recurrent infection were five and nine. Furthermore, HSV-IgA antibody was found in serum and CSF of all five patients with HSV encephalitis in the second week after onset of symptoms, indicating the usefulness of the assay as a noninvasive technique for diagnosing HSV encephalitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983012     DOI: 10.1002/jmv.1890150211

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virus-specific immunoglobulin M, A and G in patients with varicella or herpes zoster.

Authors:  A M van Loon; J T van der Logt; F W Heessen; M C Heeren; J Zoll
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

2.  Demonstration of herpes simplex virus DNA in CSF cells by in situ hybridization for early diagnosis of herpes encephalitis.

Authors:  S Bamborschke; A Porr; M Huber; W D Heiss
Journal:  J Neurol       Date:  1990-04       Impact factor: 4.849

3.  Herpes simplex virus specific antibody determined by immunoblotting in cerebrospinal fluid of a patient with the Guillain-Barré syndrome.

Authors:  H J Bernsen; A M Van Loon; R F Poels; W I Verhagen; C W Frenken
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

4.  Virus-specific IgA in serum, saliva, and tears of children with measles.

Authors:  M G Friedman; M Phillip; R Dagan
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

5.  Serologic detection of active infections with human herpes viruses (CMV, EBV, HSV, VZV): diagnostic potential of IgA class and IgG subclass-specific antibodies.

Authors:  H W Doerr; M Rentschler; G Scheifler
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

6.  Diagnosis of herpes simplex virus encephalitis by detection of virus-specific immunoglobulins A and G in serum and cerebrospinal fluid by using an antibody-capture enzyme-linked immunosorbent assay.

Authors:  A M van Loon; J T van der Logt; F W Heessen; B Postma; M F Peeters
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

7.  Secreted portion of glycoprotein g of herpes simplex virus type 2 is a novel antigen for type-discriminating serology.

Authors:  Staffan Görander; Bo Svennerholm; Jan-Ake Liljeqvist
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.